Immunohistochemical studies of the hyaluronan (HA)-receptor (R), origi
nally found on liver endothelial cells (LEC) and related to the interc
ellular adhesion molecule 1 (ICAM-1), showed that polyclonal antibodie
s against HARLEC (HA receptor on LEC) also stain structures in mouse m
astocytomas, mainly vessels. To test if intravenously administered HA
might target the tumour receptors in vivo, mice carrying an inoculated
mastocytoma in one hind leg muscle were injected in the tail vein wit
h I-125-tyrosine (T)-labelled HA and killed 75 min after injection whe
n organs and tissues were checked for radioactivity. When doses exceed
ing the binding capacity of the liver were injected, a significant inc
rease in radioactivity (up to five-fold) within the tumour tissue was
found. The weight adjusted difference between control and tumour tissu
e was greater for smaller tumours, probably due to necrosis in the lar
ger. HA-staining of tumours from animals receiving I-125-T-HA, showed
HA in areas that also stained weakly for ICAM-1 using monoclonal antib
odies. ICAM-1 staining was dramatically increased after hyaluronidase
treatment of the sections, indicating that the HA is bound to these re
ceptors and thereby blocks antibody recognition.